US7534107B2 - Inoculation training kit - Google Patents

Inoculation training kit Download PDF

Info

Publication number
US7534107B2
US7534107B2 US10/552,883 US55288305A US7534107B2 US 7534107 B2 US7534107 B2 US 7534107B2 US 55288305 A US55288305 A US 55288305A US 7534107 B2 US7534107 B2 US 7534107B2
Authority
US
United States
Prior art keywords
simulated
body part
blood
inoculation
simulated body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related, expires
Application number
US10/552,883
Other versions
US20060204939A1 (en
Inventor
Ryan S. Bardsley
Steven L. Dawson
Robert Waddington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Priority to US10/552,883 priority Critical patent/US7534107B2/en
Assigned to THE GENERAL HOSPITAL CORPORATION reassignment THE GENERAL HOSPITAL CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WADDINGTON, ROBERT, BARDSLEY, RYAN S, DAWSON, STEVEN L
Assigned to THE GENERAL HOSPITAL CORPORATION reassignment THE GENERAL HOSPITAL CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BARDSLEY, RYAN S, DAWSON, STEVEN L, WADDINGTON, ROBERT
Publication of US20060204939A1 publication Critical patent/US20060204939A1/en
Application granted granted Critical
Publication of US7534107B2 publication Critical patent/US7534107B2/en
Assigned to US GOVERNMENT - SECRETARY FOR THE ARMY reassignment US GOVERNMENT - SECRETARY FOR THE ARMY CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS). Assignors: THE GENERAL HOSPITAL CORPORATION
Expired - Fee Related legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G09EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09BEDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
    • G09B23/285Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine for injections, endoscopy, bronchoscopy, sigmoidscopy, insertion of contraceptive devices or enemas
    • GPHYSICS
    • G09EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09BEDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
    • G09B23/30Anatomical models
    • G09B23/34Anatomical models with removable parts

Definitions

  • This invention relates generally to medical inoculations and, more particularly, to an inoculation training kit.
  • Smallpox was essentially eradicated by 1977 through a comprehensive global immunization program. Therefore, smallpox vaccinations were globally terminated in 1977. As a result, people born after 1977 are unlikely to have been vaccinated against smallpox, and those vaccinated in 1977 or prior are unlikely to still be protected against the smallpox virus. Though smallpox was eradicated from the worldwide human population, smallpox virus samples still exist in various laboratories worldwide.
  • a smallpox vaccination is administered using a bifurcated needle to administer the vaccination intradermally, unlike the more typical type of vaccination administered using a hypodermic needle in an intramuscular injection.
  • intradermal technique it is important to administer the vaccination at the correct depth into the skin of a patient, and also to be familiar with characteristics of scarification that occur days after the vaccination to determine if the vaccination was properly administered and to determine if the patient had the proper reaction.
  • health care workers have not used intradermal techniques since 1977 to administer smallpox vaccinations, it is possible that, if the need arises to rapidly perform smallpox vaccinations, the health care workers will not be able to properly administer the smallpox vaccinations and will not be able to properly interpret the resulting scarification.
  • the smallpox vaccine uses live vacinia virus (similar to cowpox) to induce immunity to variola virus (smallpox). Therefore, when administering a smallpox vaccination, it is desirable to reduce or eliminate contamination of other people with the vacinia virus. Methods practiced decades ago to administer smallpox vaccinations were suitable for the elimination of contamination to the other people. It is possible that health care workers have not been trained in the techniques necessary to eliminate the contamination to other people by the vacinia virus.
  • the present invention provides an inoculation training kit suitable to train health care workers in proper techniques used in an intradermal smallpox inoculation. While the training kit is discussed for training proper techniques used in the smallpox inoculation, it should be understood that, in other embodiments, an inoculation kit can provide training in proper techniques used in other types of inoculations, including but not limited to, intramuscular injections.
  • an inoculation training kit includes a holding container for holding an inoculation needle and a simulated body part.
  • the simulated body part provides a substantially realistic sensory feedback associated with practice inoculations applied with the inoculation needle to the simulated body part.
  • a simulated body part includes a simulated skin covering and a blood container disposed within the simulated skin covering containing simulated blood.
  • the simulated body part provides a substantially realistic sensory feedback associated with practice inoculations applied to the simulated body part.
  • a holding apparatus in accordance with another aspect of the present invention includes at least one compartment adapted to hold a vial of vaccine in an upright position, while exposing an end of the vial to be accessible to an inoculation needle.
  • the holding apparatus also includes at least one compartment adapted to hold a vial of vaccine at an angle between about thirty and sixty degrees while exposing the end of the vial to be accessible to the inoculation needle.
  • FIG. 1 is a pictorial showing a disassembled inoculation training kit of the present invention
  • FIG. 2 is a diagram showing the inoculation training kit of FIG. 1 when assembled
  • FIGS. 3-3C are diagrams that together show a simulated body part, which can be a part of the inoculation training kit of FIGS. 1 and 2 ;
  • FIG. 4 is a diagram showing a cap, which can be a part of the inoculation training kit of FIGS. 1 and 2 ;
  • FIG. 5 is a diagram showing a plurality of inoculation training kits within a shipping container along with a stand used with the inoculation training kits;
  • FIG. 6 is a diagram showing training materials, which can be a part of the inoculation training kit of FIGS. 1 and 2 ;
  • FIG. 7 is a diagram showing an alternate arrangement of portions of a simulated body part, which can be a part of the inoculation training kit of FIGS. 1 and 2 ;
  • FIG. 8 is a portion of the alternate arrangement of FIG. 7 ;
  • FIG. 9 is a diagram showing an alternate arrangement of an assembled inoculation training kit.
  • an exemplary disassembled inoculation training kit 10 can include and outer container 12 and an inner container 14 adapted to fit within the outer container 12 .
  • the inoculation training kit 10 also includes a simulated body part 16 , which is adapted to couple to a stand 11 .
  • the simulated body part 16 corresponds to an arm
  • the stand 18 corresponds to a shoulder.
  • a simulated body part and stand can represent other body parts.
  • At least one bifurcated inoculation needle 32 is provided to allow a user to perform practice injections with the inoculation needle 32 applied to the simulated body part 16 .
  • the simulated body part 16 is further described in conjunction with FIGS. 3-3C , 7 , and 8 below.
  • the inoculation training kit 10 can also include a reconstitution kit having a first vial 24 a filled with powdered vaccine, a second vial 24 b filled with diluent liquid, a syringe 31 with a needle 31 of approximately twenty-one gauge, and a vented needle 31 .
  • the reconstitution kit allows a user to create a simulated vial of smallpox vaccine, in the same way that would be done for a real vial of vaccine.
  • the user uses the syringe 31 to draw diluent from the second vial 24 b with the needle 31 and injects the diluent with the vented needle 31 into the first vial 24 a containing the powdered vaccine.
  • the vented needle 31 allows air to escape from the first vial 24 a as the diluent is injected.
  • the inoculation training kit 10 can also include one or more of rubber gloves 35 , hand sanitizer 22 , gauze pads 25 , a biohazard disposal bag 28 , a surgical marker 30 , adhesive dressings 34 , a compact disc (CD) 36 , and a CD tutorial pamphlet 37 .
  • the CD 36 can have audio, visual, or both audio and visual information thereon, providing instructions in proper techniques for administering the smallpox vaccination, proper appearance of the inoculation site in the days following the inoculation, and proper techniques for keeping others from becoming infected with the vaccine.
  • the inoculation training kit 10 can also include at least one end cap 26 a adapted to retain the above items in the inner container 14 , during transport of the inoculation training kit. As described below in conjunction with FIG. 4 , one or more of the end caps (only 26 a shown) can have features to assist with the inoculation.
  • an assembled inoculation training kit 50 corresponds to the disassembled inoculation training kit 10 of FIG. 1 .
  • the inner container 14 and the simulated body part 16 are adapted to fit within the outer container 12 .
  • End caps 26 a , 26 b retain one or more of the first vial 24 a ( FIG. 1 ) filled with powdered vaccine, the second vial 24 b ( FIG. 1 ) filled with diluent liquid, the syringe 31 ( FIG. 1 ) with the needle 31 and the vented needle 31 , the rubber gloves 35 ( FIG. 1 ), the hand sanitizer 22 ( FIG. 1 ), the gauze pads 25 ( FIG.
  • FIG. 1 the biohazard disposal bag 28 ( FIG. 1 ), the surgical marker 30 ( FIG. 1 ), the adhesive dressings 34 ( FIG. 1 ), the compact disc (CD) 36 ( FIG. 1 ), and the CD tutorial pamphlet 37 ( FIG. 1 ) within the inner container 14 during transport.
  • End caps 52 , 54 retain the inner container 14 and the simulated body part 16 within the outer container during transport.
  • the stand 18 shown in FIG. 1 is separately packaged for transport as shown in conjunction with FIG. 5 below.
  • a simulated body part 100 corresponds to the simulated body part 16 of FIGS. 1 and 2 .
  • the simulated body part 100 includes blood containers 104 a - 104 c containing simulated blood (not shown).
  • the blood containers 104 a - 104 c can be disposed between a simulated skin covering 102 and an inner core 110 .
  • the blood containers 104 a - 104 c each include a respective blood bag 106 a - 106 c with a respective sponge 108 a - 108 c disposed therein containing the simulated blood.
  • a small amount of the simulated blood is released from one of the sponges 108 a - 108 c through the respective blood bag 104 a - 104 c and through the simulated skin 102 .
  • the small amount of simulated blood may be released only after a number of stabs with the bifurcated needle.
  • the simulated skin 102 has a thickness of ranging from about twenty to forty mils and a durometer in the range of about sixty to eighty Shore A.
  • the blood bags 106 a - 106 c have a wall thickness in the range of about one to three mils and a durometer in the range of about eighty to ninety-five Shore A.
  • the simulated blood within the sponges 108 a - 108 c has a viscosity in the range of about one hundred to two hundred fifty cps.
  • the sponges 108 a - 108 c each have a durometer in the range of about zero to ten Shore A, and a thickness in the range of about one hundred twenty to two hundred mils.
  • the sponges are each capable of holding about twenty-five to forty cubic centimeters of the simulated blood.
  • the inner core has a durometer in the range of about thirty to forty-five Shore A.
  • the simulated skin covering 102 , the blood bags 106 a - 106 c , the sponges 108 a - 108 c , and the inner core 110 are made from a urethane material, for example polyurethane, providing life-like characteristics.
  • the simulated body part 100 can also have a bore 112 to accept a shaft portion of a stand, for example, of the stand 18 of FIG. 1 , for positioning the simulated body part 100 on the stand 18 .
  • the simulated body part 100 can also have one or more ferrous portions 114 a - 114 c having attraction to a magnet (not shown) associated with the stand 18 , for retaining the simulated body part 100 to the stand 18 .
  • the simulated body part 100 can be retained to the stand 18 ( FIG. 1 ) in a variety of ways, including but not limited to, latches, Velcro®, and pins.
  • a practice inoculation involves reconstituting a simulated vial of vaccine into the vial of powered vaccine 24 a ( FIG. 1 ) as described above in conjunction with FIG. 1 , applying fluid from the simulated vial of vaccine 24 a ( FIG. 1 ) to the bifurcated needle 32 ( FIG. 1 ) and applying one or more practice jabs with the bifurcated needle 32 to the simulated body part 100 , and in particular to the simulated skin covering 102 in the vicinity of one of the blood containers 104 a - 104 c .
  • a smallpox inoculation includes about fifteen stabs with the bifurcated needle if a person to whom the inoculation is administered has never had a smallpox inoculation. To a person previously vaccinated, about three stabs are applied.
  • the simulated body part 100 provides a substantially realistic sensory feedback to the user.
  • the simulated body part 100 can provide a substantially realistic haptic feedback to the user, wherein the simulated body part 100 has a substantially realistic hardness and a substantially realistic elastic deformation in response to the practice inoculation.
  • the simulated body part 100 can provide a substantially realistic visual feedback to the user.
  • the practice inoculations tend to create one or more punctures of the simulated skin covering 102 and in one of the blood containers 104 a - 104 b containing the simulated blood. The punctures can release a small amount of the simulated blood at the location where the practice inoculation occurred.
  • the simulated body part 100 can release a small amount of the simulated blood when about three practice inoculations are applied and a greater amount of the simulated blood when about fifteen practice inoculations are applied.
  • the viscosity of the simulated blood, the thickness and hardness of the simulated skin covering 102 , the thickness and hardness of the blood bags 104 a - 104 c , the thickness and hardness of the sponges 108 a - 108 c , and the hardness of the inner core 110 are selected to provide the realistic sensory feedback.
  • the simulated body part 100 can have other ranges of characteristics, which in some combinations provide a reduced but still effective realistic sensory feedback.
  • the simulated skin 102 has a thickness of ranging from about ten to one hundred mils and a durometer in the range of about twenty to eighty Shore A.
  • the blood bags 106 a - 106 c have a wall thickness in the range of about one to twenty mils and a durometer in the range of about forty to one hundred twenty Shore A.
  • the simulated blood within the sponges 108 a - 108 c has a viscosity in the range of about fifty to five hundred cps.
  • the sponges 108 a - 108 c each have a durometer in the range of about zero to thirty Shore A, and a thickness in the range of about sixty to four hundred mils.
  • the sponges are each capable of holding about ten to eighty cubic centimeters of the simulated blood.
  • the inner core has a durometer in the range of about fifteen to ninety Shore A.
  • blood containers 104 a - 104 c are shown, each disposed at a relative angle of about one hundred twenty degrees from others of the blood containers 104 a - 104 c , in other embodiments, more than three or fewer than three blood containers can be used and at different relative angles.
  • one blood container surrounding the inner core 110 is provided, having one blood bag and one sponge disposed therein containing the simulated blood.
  • no inner core 110 is included, and the one or more blood containers 104 a - 104 c are merely disposed within the simulated skin covering 102 .
  • the end cap 26 a can have at least one compartment 152 that can hold one or more of the simulated vials of vaccine 24 a ( FIG. 1 ) in a generally upright position, not subject to being spilled, when placed in the compartment 152 .
  • the cap 26 a can have another compartment 150 that can hold one or more of the simulated vials of vaccine 24 a ( FIG. 1 ) in a position between approximately thirty and sixty degrees from upright, not subject to being spilled, when placed in the compartment 150 .
  • the cap can have yet another compartment 154 adapted to hold a top cap (not shown) of the simulated vial of vaccine 24 a .
  • Another compartment 156 can be used to hold other items, for example, the bifurcated needles 32 ( FIG. 1 ).
  • the same compartments having the same functions can be provided in an alternate piece that does not form the cap 26 a for the inner container 14 .
  • the alternate piece can be retained within the inner container 14 during transport.
  • the cap 26 a having the compartments 150 - 156 has been described to be part of the inoculation kit 10 ( FIG. 1 )
  • the alternate piece having the same features and functions as the cap 26 a can be provided apart from the inoculation training kit, to hold vials of vaccine during real inoculations.
  • cap 26 a is shown to have the compartments 150 - 156 it should be apparent that others of the caps 26 b , 52 , 54 ( FIG. 2 ) can also have compartments, which may be the same or different than the compartments 150 - 156 in the cap 26 a.
  • an exemplary transportation box 200 can hold one or more of the assembled inoculation training kits, for example one or more of the assembled inoculation training kits 50 shown in FIG. 2 .
  • the transportation box 200 can also hold the frame 18 of FIG. 1 .
  • the training materials 36 , 37 can provide a visual description 250 of the appearance of the site of a real smallpox vaccination as a scar forms and heals on the arm of a real patient.
  • the visual description 250 can include a plurality of descriptions associated with different patients, for example day-six descriptions 252 , 258 from two patients, day-eight descriptions 254 , 260 from two patients, and day-ten descriptions 256 , 262 from two patients.
  • the inoculation training kit is not limited to smallpox vaccinations or to a bifurcated needle. Many types of vaccinations are applied by injection with a hypodermic needle into a muscle of a patient. Therefore, in an alternate arrangement, the inoculation training kit can have one or more hypodermic needles and associated syringes in place of or in addition to the one or more bifurcated needles.
  • a CD similar to the CD 36 ( FIG. 1 ) can be provided to teach a user about other types of inoculations.
  • the simulated body part 100 ( FIG. 3-3C ) can be adapted to provide the realistic sensory feedback, including release of a predetermined amount of the simulated blood when practice injections are applied with the hypodermic needle.
  • an alternate arrangement 300 of portions of a simulated body part includes an alternate arrangement for providing the substantially realistic visual feedback to the user (i.e., the release of simulated blood).
  • the alternate arrangement 300 includes a simulated skin covering 302 , which can be the same as or similar to the simulated skin covering 102 of FIGS. 3-3C .
  • a region 314 includes an orifice 316 through the simulated skin covering 302 .
  • a piezoelectric switch 308 a - 308 c (also denoted 308 herein) is provided in the region 314 .
  • the piezoelectric switch 306 can include a piezoelectric film layer 306 a , an insulating layer 306 b , and a conductive reference layer 306 c.
  • a blood reservoir 310 a holding a volume of simulated blood 310 b is fluidly coupled to the orifice 316 .
  • a control circuit 306 is adapted to activate one or more features 310 c associated with the blood reservoir 310 a in accordance with the signals received from the piezoelectric switch 308 , causing a small amount of the simulated blood 310 b to be released from the orifice 316 , giving a user a substantially realistic visual feedback.
  • the one or more features 310 c are Nitinol bands adapted to generate a hydraulic force in the blood reservoir 310 a in response to a signal 312 from the control circuit 306 .
  • Nitinol (Nickel Titanium Naval Ordnance Laboratory) is a nickel-titanium alloy known to have a shape memory and to deform or return to its original shape upon application of a temperature. The temperature can be induced by application of a voltage or current.
  • the blood reservoir 310 a having the one or more Nitinol bands 310 c is described more fully below in conjunction with FIG. 8 .
  • a user applies one or more practice inoculations to the region 314 .
  • the region 308 can be clearly marked on the simulated skin covering 302 .
  • the piezoelectric switch 308 provides a signal to the control circuit 306 upon each practice inoculation, i.e., upon each practice stab with a bifurcated needle 32 ( FIG. 1 ) upon the region 314 .
  • the practice inoculations can be counted by the control circuit 306 .
  • control circuit 306 After a predetermined number of practice inoculations have been applied, the control circuit 306 generates a signal 312 , causing the one or more Nitinol bands 310 c to deform, resulting in a hydraulic force upon the blood reservoir 310 a and a release of a small amount of the simulated blood 310 b from the orifice 316 .
  • the predetermined number of inoculations i.e., practice stabs with the inoculation needle
  • the predetermined number of inoculations can be any number.
  • a person who has never received a smallpox inoculation receives about fifteen stabs with the bifurcated needle in a real smallpox vaccination, and a person who has previously received a smallpox vaccination is subjected to about three stabs with the needle. Therefore, in one particular embodiment, the control circuit 306 can be selectively set to count either about fifteen or about three practice inoculations and to provide the signal 312 to the one or more Nitinol bands 310 c accordingly.
  • piezoelectric switch 308 While a piezoelectric switch 308 is shown and described, it will be understood that a variety of types of switch can be used, including but not limited to, a mechanical switch.
  • apparatus 400 can be used to generate the hydraulic force described above.
  • the apparatus 400 includes a blood reservoir 402 having an outlet 410 and containing simulated blood 404 .
  • Nitinol bands 406 a , 406 b surround at least a portion of the blood reservoir 402 .
  • the apparatus 400 can include a piezoelectric switch 414 , which can correspond, for example, to the piezoelectric switch 408 of FIG. 7 .
  • the blood reservoir 402 can correspond, for example, to the blood reservoir 310 a having the simulated blood 310 b of FIG. 7 and the Nitinol bands 406 a , 406 b can correspond to the one or more Nitinol bands 310 c of FIG. 7 .
  • the Nitinol bands 406 a , 406 b are adapted to deform when a voltage, V+, V ⁇ , is applied to them.
  • the amount of deformation is proportional to the voltage. Therefore, it will be understood that the Nitinol bands 406 a , 406 b can provide a hydraulic force to force an amount of the simulated blood 404 out of the outlet 410 in response to the voltage.
  • a control circuit for example, the control circuit 306 shown in FIG. 7 , can be used to provide the voltages V+ and V ⁇ to one or more of the Nitinol bands 406 a , 406 b .
  • the voltages V+ and V ⁇ can correspond, for example, to the signal 312 of FIG. 7 .
  • the control circuit 306 as described above, can count a number of practice jabs with a needle, for example upon the region 314 ( FIG. 7 ) having the piezoelectric switch 414 .
  • the control circuit 306 can provide the voltage to the Nitinol bands 406 a , 406 b accordingly.
  • Nitinol bands 306 a , 306 b adapted to provide the hydraulic force are shown, other configurations of Nitinol material can also be used.
  • a spring made from the Nitinol material can be used.
  • an inoculation training kit 500 can be packaged in a tray 502 having a removable cover 504 .
  • the inoculation training kit can contain a simulated body part 506 , and a CD 508 having training instructions thereon.
  • the simulated body part 506 can be the same as or similar to the simulated body part 16 of FIGS. 1 and 2 , and the simulated body part 100 of FIG. 3 .
  • the CD 508 can be the same as or similar to the CD 36 shown in FIG. 1 .
  • the inoculation training kit 500 can include some or all of the other items described in conjunction with the inoculation training kit 10 of FIG. 1 , including but not limited to one or more of the first vial 24 a ( FIG.

Abstract

An inoculation training kit contains a simulated body part and at least one inoculation needle, allowing a user to practice inoculations upon the simulated body part.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a National Stage application under 35 U.S.C. §371 of and claims the benefit of International Application No. PCT/US2004/011346 filed on Apr. 13, 2004, which claims priority to Provisional Patent Applications 60/467,502, filed on May 2, 2003 and 60/462,674, filed on Apr. 14, 2003, which are hereby incorporated by reference.
FIELD OF THE INVENTION
This invention relates generally to medical inoculations and, more particularly, to an inoculation training kit.
BACKGROUND OF THE INVENTION
A variety of health risks have been associated with terrorist attacks in the United States and elsewhere. Past terrorist attacks have included the use of weapons and explosives as well as the use of poisons, for example, Ricin and infectious agents, for example, Anthrax. There is a growing concern that terrorists may make use in the future of other infectious agents, and in particular, smallpox.
Smallpox was essentially eradicated by 1977 through a comprehensive global immunization program. Therefore, smallpox vaccinations were globally terminated in 1977. As a result, people born after 1977 are unlikely to have been vaccinated against smallpox, and those vaccinated in 1977 or prior are unlikely to still be protected against the smallpox virus. Though smallpox was eradicated from the worldwide human population, smallpox virus samples still exist in various laboratories worldwide.
Following the attack on the World Trade Center and the Anthrax attack on the federal building in Washington D.C. in 2001, President Bush initiated a national smallpox vaccination program, requesting near-term immunization of military personnel deployed to certain regions. Furthermore, if a smallpox attack occurs, the Center for Disease Control (CDC) suggests rapid vaccination of a variety of other people, including those directly exposed, contacts of those directly exposed, health care workers responsible for the care of those with confirmed infection, laboratory workers who handle smallpox specimens, allied personnel handling laundry, waste, and dead bodies associated with smallpox victims, law enforcement personnel, and EMTs.
A smallpox vaccination is administered using a bifurcated needle to administer the vaccination intradermally, unlike the more typical type of vaccination administered using a hypodermic needle in an intramuscular injection. With the intradermal technique, it is important to administer the vaccination at the correct depth into the skin of a patient, and also to be familiar with characteristics of scarification that occur days after the vaccination to determine if the vaccination was properly administered and to determine if the patient had the proper reaction. Because health care workers have not used intradermal techniques since 1977 to administer smallpox vaccinations, it is possible that, if the need arises to rapidly perform smallpox vaccinations, the health care workers will not be able to properly administer the smallpox vaccinations and will not be able to properly interpret the resulting scarification.
Unlike conventional vaccines, which are made from inactive virus particles, the smallpox vaccine uses live vacinia virus (similar to cowpox) to induce immunity to variola virus (smallpox). Therefore, when administering a smallpox vaccination, it is desirable to reduce or eliminate contamination of other people with the vacinia virus. Methods practiced decades ago to administer smallpox vaccinations were suitable for the elimination of contamination to the other people. It is possible that health care workers have not been trained in the techniques necessary to eliminate the contamination to other people by the vacinia virus.
SUMMARY OF THE INVENTION
The present invention provides an inoculation training kit suitable to train health care workers in proper techniques used in an intradermal smallpox inoculation. While the training kit is discussed for training proper techniques used in the smallpox inoculation, it should be understood that, in other embodiments, an inoculation kit can provide training in proper techniques used in other types of inoculations, including but not limited to, intramuscular injections.
In accordance with the present invention, an inoculation training kit includes a holding container for holding an inoculation needle and a simulated body part. The simulated body part provides a substantially realistic sensory feedback associated with practice inoculations applied with the inoculation needle to the simulated body part.
In accordance with another aspect of the present invention, a simulated body part includes a simulated skin covering and a blood container disposed within the simulated skin covering containing simulated blood. The simulated body part provides a substantially realistic sensory feedback associated with practice inoculations applied to the simulated body part.
In accordance with another aspect of the present invention a holding apparatus includes at least one compartment adapted to hold a vial of vaccine in an upright position, while exposing an end of the vial to be accessible to an inoculation needle. The holding apparatus also includes at least one compartment adapted to hold a vial of vaccine at an angle between about thirty and sixty degrees while exposing the end of the vial to be accessible to the inoculation needle.
With these particular arrangements, training for and application of medical inoculations is improved.
BRIEF DESCRIPTION OF THE DRAWINGS
The foregoing features of the invention, as well as the invention itself may be more fully understood from the following detailed description of the drawings, in which:
FIG. 1 is a pictorial showing a disassembled inoculation training kit of the present invention;
FIG. 2 is a diagram showing the inoculation training kit of FIG. 1 when assembled;
FIGS. 3-3C are diagrams that together show a simulated body part, which can be a part of the inoculation training kit of FIGS. 1 and 2;
FIG. 4 is a diagram showing a cap, which can be a part of the inoculation training kit of FIGS. 1 and 2;
FIG. 5 is a diagram showing a plurality of inoculation training kits within a shipping container along with a stand used with the inoculation training kits;
FIG. 6 is a diagram showing training materials, which can be a part of the inoculation training kit of FIGS. 1 and 2;
FIG. 7 is a diagram showing an alternate arrangement of portions of a simulated body part, which can be a part of the inoculation training kit of FIGS. 1 and 2; and
FIG. 8 is a portion of the alternate arrangement of FIG. 7; and
FIG. 9 is a diagram showing an alternate arrangement of an assembled inoculation training kit.
DETAILED DESCRIPTION OF THE INVENTION
Referring to FIG. 1, an exemplary disassembled inoculation training kit 10 can include and outer container 12 and an inner container 14 adapted to fit within the outer container 12. The inoculation training kit 10 also includes a simulated body part 16, which is adapted to couple to a stand 11. In this particular embodiment, the simulated body part 16 corresponds to an arm, and the stand 18 corresponds to a shoulder. However, in other embodiments, a simulated body part and stand can represent other body parts. At least one bifurcated inoculation needle 32 is provided to allow a user to perform practice injections with the inoculation needle 32 applied to the simulated body part 16. The simulated body part 16 is further described in conjunction with FIGS. 3-3C, 7, and 8 below.
The inoculation training kit 10 can also include a reconstitution kit having a first vial 24 a filled with powdered vaccine, a second vial 24 b filled with diluent liquid, a syringe 31 with a needle 31 of approximately twenty-one gauge, and a vented needle 31. In practice, the reconstitution kit allows a user to create a simulated vial of smallpox vaccine, in the same way that would be done for a real vial of vaccine. The user uses the syringe 31 to draw diluent from the second vial 24 b with the needle 31 and injects the diluent with the vented needle 31 into the first vial 24 a containing the powdered vaccine. The vented needle 31 allows air to escape from the first vial 24 a as the diluent is injected.
The inoculation training kit 10 can also include one or more of rubber gloves 35, hand sanitizer 22, gauze pads 25, a biohazard disposal bag 28, a surgical marker 30, adhesive dressings 34, a compact disc (CD) 36, and a CD tutorial pamphlet 37. The CD 36 can have audio, visual, or both audio and visual information thereon, providing instructions in proper techniques for administering the smallpox vaccination, proper appearance of the inoculation site in the days following the inoculation, and proper techniques for keeping others from becoming infected with the vaccine. The inoculation training kit 10 can also include at least one end cap 26 a adapted to retain the above items in the inner container 14, during transport of the inoculation training kit. As described below in conjunction with FIG. 4, one or more of the end caps (only 26 a shown) can have features to assist with the inoculation.
Referring now to FIG. 2, in which like elements of FIG. 1 are shown having like reference designations, an assembled inoculation training kit 50 corresponds to the disassembled inoculation training kit 10 of FIG. 1. The inner container 14 and the simulated body part 16 are adapted to fit within the outer container 12. End caps 26 a, 26 b retain one or more of the first vial 24 a (FIG. 1) filled with powdered vaccine, the second vial 24 b (FIG. 1) filled with diluent liquid, the syringe 31 (FIG. 1) with the needle 31 and the vented needle 31, the rubber gloves 35 (FIG. 1), the hand sanitizer 22 (FIG. 1), the gauze pads 25 (FIG. 1), the biohazard disposal bag 28 (FIG. 1), the surgical marker 30 (FIG. 1), the adhesive dressings 34 (FIG. 1), the compact disc (CD) 36 (FIG. 1), and the CD tutorial pamphlet 37 (FIG. 1) within the inner container 14 during transport. End caps 52, 54 retain the inner container 14 and the simulated body part 16 within the outer container during transport. The stand 18 shown in FIG. 1 is separately packaged for transport as shown in conjunction with FIG. 5 below.
Referring now to FIGS. 3-3C, a simulated body part 100 corresponds to the simulated body part 16 of FIGS. 1 and 2. The simulated body part 100 includes blood containers 104 a-104 c containing simulated blood (not shown). The blood containers 104 a-104 c can be disposed between a simulated skin covering 102 and an inner core 110. The blood containers 104 a-104 c each include a respective blood bag 106 a-106 c with a respective sponge 108 a-108 c disposed therein containing the simulated blood. In response to a simulated inoculation applied to the simulated skin 102 (i.e., a stab with the bifurcated needle of FIG. 1), a small amount of the simulated blood is released from one of the sponges 108 a-108 c through the respective blood bag 104 a-104 c and through the simulated skin 102. However, in another embodiment, the small amount of simulated blood may be released only after a number of stabs with the bifurcated needle.
In one embodiment, the simulated skin 102 has a thickness of ranging from about twenty to forty mils and a durometer in the range of about sixty to eighty Shore A. The blood bags 106 a-106 c have a wall thickness in the range of about one to three mils and a durometer in the range of about eighty to ninety-five Shore A. The simulated blood within the sponges 108 a-108 c has a viscosity in the range of about one hundred to two hundred fifty cps. The sponges 108 a-108 c each have a durometer in the range of about zero to ten Shore A, and a thickness in the range of about one hundred twenty to two hundred mils. The sponges are each capable of holding about twenty-five to forty cubic centimeters of the simulated blood. The inner core has a durometer in the range of about thirty to forty-five Shore A.
In one particular embodiment, the simulated skin covering 102, the blood bags 106 a-106 c, the sponges 108 a-108 c, and the inner core 110 are made from a urethane material, for example polyurethane, providing life-like characteristics.
The simulated body part 100 can also have a bore 112 to accept a shaft portion of a stand, for example, of the stand 18 of FIG. 1, for positioning the simulated body part 100 on the stand 18. The simulated body part 100 can also have one or more ferrous portions 114 a-114 c having attraction to a magnet (not shown) associated with the stand 18, for retaining the simulated body part 100 to the stand 18.
While magnets and the ferrous portions 114 a-114 c are described above, one of ordinary skill in the art will understand that the simulated body part 100 can be retained to the stand 18 (FIG. 1) in a variety of ways, including but not limited to, latches, Velcro®, and pins.
In application, a user performs practice inoculations with one of the bifurcated needles 32 of FIG. 1. A practice inoculation involves reconstituting a simulated vial of vaccine into the vial of powered vaccine 24 a (FIG. 1) as described above in conjunction with FIG. 1, applying fluid from the simulated vial of vaccine 24 a (FIG. 1) to the bifurcated needle 32 (FIG. 1) and applying one or more practice jabs with the bifurcated needle 32 to the simulated body part 100, and in particular to the simulated skin covering 102 in the vicinity of one of the blood containers 104 a-104 c. As is known, a smallpox inoculation includes about fifteen stabs with the bifurcated needle if a person to whom the inoculation is administered has never had a smallpox inoculation. To a person previously vaccinated, about three stabs are applied.
The simulated body part 100 provides a substantially realistic sensory feedback to the user. For example, the simulated body part 100 can provide a substantially realistic haptic feedback to the user, wherein the simulated body part 100 has a substantially realistic hardness and a substantially realistic elastic deformation in response to the practice inoculation. For another example, the simulated body part 100 can provide a substantially realistic visual feedback to the user. The practice inoculations tend to create one or more punctures of the simulated skin covering 102 and in one of the blood containers 104 a-104 b containing the simulated blood. The punctures can release a small amount of the simulated blood at the location where the practice inoculation occurred. For example, the simulated body part 100 can release a small amount of the simulated blood when about three practice inoculations are applied and a greater amount of the simulated blood when about fifteen practice inoculations are applied. The viscosity of the simulated blood, the thickness and hardness of the simulated skin covering 102, the thickness and hardness of the blood bags 104 a-104 c, the thickness and hardness of the sponges 108 a-108 c, and the hardness of the inner core 110 are selected to provide the realistic sensory feedback.
While a particular embodiment of the simulated body part 100 having particular ranges of characteristics is described above to provide the realistic sensory feedback, it should be recognized that in other embodiments, the simulated body part 100 can have other ranges of characteristics, which in some combinations provide a reduced but still effective realistic sensory feedback. For example, in another embodiment, the simulated skin 102 has a thickness of ranging from about ten to one hundred mils and a durometer in the range of about twenty to eighty Shore A. The blood bags 106 a-106 c have a wall thickness in the range of about one to twenty mils and a durometer in the range of about forty to one hundred twenty Shore A. The simulated blood within the sponges 108 a-108 c has a viscosity in the range of about fifty to five hundred cps. The sponges 108 a-108 c each have a durometer in the range of about zero to thirty Shore A, and a thickness in the range of about sixty to four hundred mils. The sponges are each capable of holding about ten to eighty cubic centimeters of the simulated blood. The inner core has a durometer in the range of about fifteen to ninety Shore A.
While three blood containers 104 a-104 c are shown, each disposed at a relative angle of about one hundred twenty degrees from others of the blood containers 104 a-104 c, in other embodiments, more than three or fewer than three blood containers can be used and at different relative angles. For example, in one embodiment, one blood container surrounding the inner core 110 is provided, having one blood bag and one sponge disposed therein containing the simulated blood. Also, in an alternate embodiment, no inner core 110 is included, and the one or more blood containers 104 a-104 c are merely disposed within the simulated skin covering 102.
Referring now to FIG. 4, in which like elements of FIGS. 1 and 2 are shown having like reference designations, the end cap 26 a can have at least one compartment 152 that can hold one or more of the simulated vials of vaccine 24 a (FIG. 1) in a generally upright position, not subject to being spilled, when placed in the compartment 152. The cap 26 a can have another compartment 150 that can hold one or more of the simulated vials of vaccine 24 a (FIG. 1) in a position between approximately thirty and sixty degrees from upright, not subject to being spilled, when placed in the compartment 150. The cap can have yet another compartment 154 adapted to hold a top cap (not shown) of the simulated vial of vaccine 24 a. Another compartment 156 can be used to hold other items, for example, the bifurcated needles 32 (FIG. 1).
While a cap having compartments 150-156 is shown, in another embodiment, the same compartments having the same functions can be provided in an alternate piece that does not form the cap 26 a for the inner container 14. In this embodiment, the alternate piece can be retained within the inner container 14 during transport. Also, while the cap 26 a having the compartments 150-156 has been described to be part of the inoculation kit 10 (FIG. 1), the alternate piece having the same features and functions as the cap 26 a can be provided apart from the inoculation training kit, to hold vials of vaccine during real inoculations.
While the cap 26 a is shown to have the compartments 150-156 it should be apparent that others of the caps 26 b, 52, 54 (FIG. 2) can also have compartments, which may be the same or different than the compartments 150-156 in the cap 26 a.
Referring now to FIG. 5, an exemplary transportation box 200 can hold one or more of the assembled inoculation training kits, for example one or more of the assembled inoculation training kits 50 shown in FIG. 2. The transportation box 200 can also hold the frame 18 of FIG. 1.
Referring now to FIG. 6, the training materials 36, 37 (FIG. 1), and in particular, the CD 36 of FIG. 1, can provide a visual description 250 of the appearance of the site of a real smallpox vaccination as a scar forms and heals on the arm of a real patient. The visual description 250 can include a plurality of descriptions associated with different patients, for example day-six descriptions 252, 258 from two patients, day-eight descriptions 254, 260 from two patients, and day-ten descriptions 256, 262 from two patients.
As is known, a successful smallpox inoculation is indicated by particular scarification that occurs in the days after an intradermal inoculation with smallpox vaccine. Therefore, it is very important in the training process to teach the user what the scarification should look like in the days following the smallpox inoculation.
While a smallpox vaccination applied with a bifurcated needle is described in conjunction with the above figures, the inoculation training kit is not limited to smallpox vaccinations or to a bifurcated needle. Many types of vaccinations are applied by injection with a hypodermic needle into a muscle of a patient. Therefore, in an alternate arrangement, the inoculation training kit can have one or more hypodermic needles and associated syringes in place of or in addition to the one or more bifurcated needles. A CD similar to the CD 36 (FIG. 1) can be provided to teach a user about other types of inoculations. The simulated body part 100 (FIG. 3-3C) can be adapted to provide the realistic sensory feedback, including release of a predetermined amount of the simulated blood when practice injections are applied with the hypodermic needle.
Referring now to FIG. 7, an alternate arrangement 300 of portions of a simulated body part, for example the simulated body part 100 of FIGS. 3-3C, includes an alternate arrangement for providing the substantially realistic visual feedback to the user (i.e., the release of simulated blood). The alternate arrangement 300 includes a simulated skin covering 302, which can be the same as or similar to the simulated skin covering 102 of FIGS. 3-3C. A region 314 includes an orifice 316 through the simulated skin covering 302. A piezoelectric switch 308 a-308 c (also denoted 308 herein) is provided in the region 314. The piezoelectric switch 306 can include a piezoelectric film layer 306 a, an insulating layer 306 b, and a conductive reference layer 306 c.
A blood reservoir 310 a holding a volume of simulated blood 310 b is fluidly coupled to the orifice 316. A control circuit 306 is adapted to activate one or more features 310 c associated with the blood reservoir 310 a in accordance with the signals received from the piezoelectric switch 308, causing a small amount of the simulated blood 310 b to be released from the orifice 316, giving a user a substantially realistic visual feedback. In one particular embodiment, the one or more features 310 c are Nitinol bands adapted to generate a hydraulic force in the blood reservoir 310 a in response to a signal 312 from the control circuit 306. Nitinol (Nickel Titanium Naval Ordnance Laboratory) is a nickel-titanium alloy known to have a shape memory and to deform or return to its original shape upon application of a temperature. The temperature can be induced by application of a voltage or current. The blood reservoir 310 a having the one or more Nitinol bands 310 c is described more fully below in conjunction with FIG. 8.
In operation, a user applies one or more practice inoculations to the region 314. The region 308 can be clearly marked on the simulated skin covering 302. The piezoelectric switch 308 provides a signal to the control circuit 306 upon each practice inoculation, i.e., upon each practice stab with a bifurcated needle 32 (FIG. 1) upon the region 314. The practice inoculations can be counted by the control circuit 306. After a predetermined number of practice inoculations have been applied, the control circuit 306 generates a signal 312, causing the one or more Nitinol bands 310 c to deform, resulting in a hydraulic force upon the blood reservoir 310 a and a release of a small amount of the simulated blood 310 b from the orifice 316.
The predetermined number of inoculations (i.e., practice stabs with the inoculation needle) that result in activation of the Nitinol bands 310 c can be any number. As described above, a person who has never received a smallpox inoculation receives about fifteen stabs with the bifurcated needle in a real smallpox vaccination, and a person who has previously received a smallpox vaccination is subjected to about three stabs with the needle. Therefore, in one particular embodiment, the control circuit 306 can be selectively set to count either about fifteen or about three practice inoculations and to provide the signal 312 to the one or more Nitinol bands 310 c accordingly.
While a piezoelectric switch 308 is shown and described, it will be understood that a variety of types of switch can be used, including but not limited to, a mechanical switch.
Referring now to FIG. 8, apparatus 400 can be used to generate the hydraulic force described above. The apparatus 400 includes a blood reservoir 402 having an outlet 410 and containing simulated blood 404. Nitinol bands 406 a, 406 b surround at least a portion of the blood reservoir 402. The apparatus 400 can include a piezoelectric switch 414, which can correspond, for example, to the piezoelectric switch 408 of FIG. 7. The blood reservoir 402 can correspond, for example, to the blood reservoir 310 a having the simulated blood 310 b of FIG. 7 and the Nitinol bands 406 a, 406 b can correspond to the one or more Nitinol bands 310 c of FIG. 7.
In operation, the Nitinol bands 406 a, 406 b are adapted to deform when a voltage, V+, V−, is applied to them. The amount of deformation is proportional to the voltage. Therefore, it will be understood that the Nitinol bands 406 a, 406 b can provide a hydraulic force to force an amount of the simulated blood 404 out of the outlet 410 in response to the voltage.
A control circuit, for example, the control circuit 306 shown in FIG. 7, can be used to provide the voltages V+ and V− to one or more of the Nitinol bands 406 a, 406 b. The voltages V+ and V− can correspond, for example, to the signal 312 of FIG. 7. The control circuit 306, as described above, can count a number of practice jabs with a needle, for example upon the region 314 (FIG. 7) having the piezoelectric switch 414. The control circuit 306 can provide the voltage to the Nitinol bands 406 a, 406 b accordingly.
While Nitinol bands 306 a, 306 b adapted to provide the hydraulic force are shown, other configurations of Nitinol material can also be used. For example, a spring made from the Nitinol material can be used.
Referring now to FIG. 9, in an alternate arrangement, an inoculation training kit 500 can be packaged in a tray 502 having a removable cover 504. The inoculation training kit can contain a simulated body part 506, and a CD 508 having training instructions thereon. The simulated body part 506 can be the same as or similar to the simulated body part 16 of FIGS. 1 and 2, and the simulated body part 100 of FIG. 3. The CD 508 can be the same as or similar to the CD 36 shown in FIG. 1. The inoculation training kit 500 can include some or all of the other items described in conjunction with the inoculation training kit 10 of FIG. 1, including but not limited to one or more of the first vial 24 a (FIG. 1) filled with powdered vaccine, the second vial 24 b (FIG. 1) filled with diluent liquid, the syringe 31 (FIG. 1) with the needle 31 and the vented needle 31, the rubber gloves 35 (FIG. 1), the hand sanitizer 22 (FIG. 1), the gauze pads 25 (FIG. 1), the biohazard disposal bag 28 (FIG. 1), the surgical marker 30 (FIG. 1), the adhesive dressings 34 (FIG. 1), the compact disc (CD) 36 (FIG. 1), and the CD tutorial pamphlet 37 (FIG. 1).
All references cited herein are hereby incorporated herein by reference in their entirety.
Having described preferred embodiments of the invention, it will now become apparent to one of ordinary skill in the art that other embodiments incorporating their concepts may be used. It is felt therefore that these embodiments should not be limited to disclosed embodiments, but rather should be limited only by the spirit and scope of the appended claims.

Claims (47)

1. An inoculation training kit, comprising:
a holding container, having disposed therein:
an inoculation needle; and
a simulated body part having a substantially realistic sensory feedback associated with practice inoculations applied with the inoculation needle to the simulated body parts,
wherein the holding container includes an outer cylindrical container and an inner cylindrical container, wherein the inner cylindrical container and the simulated body part are adapted to fit within the outer cylindrical container, wherein the inner cylindrical container contains the inoculation needle.
2. The inoculation training kit of claim 1, wherein the substantially realistic sensory feedback includes at least one of substantially realistic haptic feedback and substantially realistic visual feedback.
3. The inoculation training kit of claim 2, wherein the substantially realistic visual feedback includes simulated bleeding.
4. The inoculation training kit of claim 2, wherein the substantially realistic visual feedback includes elastic deformation of the simulated body part.
5. The inoculation training kit of claim 1, wherein the simulated body part includes a blood container containing simulated blood and the simulated body part is adapted to release a predetermined amount of the simulated blood in response to the practice inoculations applied with the inoculation needle to the simulated body part.
6. The inoculation training kit of claim 5, wherein the simulated blood has a viscosity of about fifty to five hundred cps.
7. The inoculation training kit of claim 5, wherein the blood container comprises a bag and a sponge disposed within the bag, wherein the sponge contains the simulated blood.
8. The inoculation training kit of claim 7, wherein a wall of the bag has a thickness of about one to twenty mils and a durometer of about forty to one hundred twenty Shore A.
9. The inoculation training kit of claim 1, wherein the simulated body part includes a simulated skin covering.
10. The inoculation training kit of claim 9, wherein the simulated skin covering has a thickness of about ten to one hundred mils and a durometer of about twenty to eighty Shore A.
11. The inoculation training kit of claim 1, wherein the simulated body part includes an inner core.
12. The inoculation training kit of claim 11, wherein the inner core has a durometer of about fifteen to ninety Shore A.
13. The inoculation training kit of claim 1, wherein the simulated body part includes:
a simulated skin covering having a thickness of about ten to one hundred mils and a durometer of about twenty to eighty Shore A;
an inner core having a durometer of about fifteen to ninety Shore A; and
a blood container containing simulated blood disposed between the simulated skin and the inner core, wherein the simulated body part is adapted to release a predetermined amount of the simulated blood in response to the practice inoculations applied with the inoculation needle to the simulated body part.
14. The inoculation training kit of claim 13, wherein the blood container includes a bag with a wall thickness of about one to twenty mils and with a durometer of about forty to one hundred twenty Shore A and having a sponge disposed within the bag containing the simulated blood having a viscosity of about fifty to five hundred cps.
15. The inoculation training kit of claim 13, wherein at least one of the simulated skin, the blood container, and the inner core is made from polyurethane.
16. The inoculation training kit of claim 1, wherein the simulated body part comprises a simulated portion of a human arm.
17. The inoculation training kit of claim 1, wherein the inoculation needle comprises a bifurcated needle.
18. The inoculation training kit of claim 1, wherein the inoculation needle comprises a hypodermic needle and a syringe adapted to couple to the hypodermic needle.
19. The inoculation training kit of claim 1, wherein the holding container has further disposed therein at least one of a disinfecting agent, a surgical glove, a vial of simulated vaccine, and instructions for administering the simulated vaccine with the inoculation needle.
20. The inoculation training kit of claim 1, wherein at least one of the outer cylindrical container and the inner cylindrical container includes at least one removable cap having at least one compartment to hold a vial of simulated vaccine in an upright position when the removable cap is removed from the inner container and placed on a generally horizontal surface and the vial of simulated vaccine is placed upright in the compartment.
21. The inoculation training kit of claim 1, further including a stand having a retention mechanism adapted to retain the simulated body part to the stand.
22. The inoculation training kit of claim 21, wherein the stand has a shape corresponding to a shoulder, and the simulated body part has a shape corresponding to a portion of an arm.
23. The inoculation training kit of claim 22, wherein the stand, when coupled to the simulated body part and disposed upon a top surface of a table, is at height corresponding to a height of a person when sitting in a chair.
24. The inoculation training kit of claim 22, wherein retention mechanism includes a magnet.
25. The inoculation training kit of claim 1, wherein the holding container comprises a holding tray having compartments adapted to hold the inoculation needle and the simulated body part.
26. The inoculation training kit of claim 25, further including a removable cover over the holding tray adapted to retain the inoculation needle and the simulated body part in the holding tray during transport.
27. The inoculation training kit of claim 1, wherein the holding container has further disposed therein instructions for administering a vaccine with the inoculation needle comprising a compact disc (CD) having the instructions disposed thereon.
28. The inoculation training kit of claim 27, wherein the holding container has a removable cap and the CD is removably coupled to a surface of the removable cap.
29. A simulated body part, comprising:
a simulated skin covering; and
a blood container containing simulated blood disposed within the simulated skin covering, wherein the simulated body part provides a substantially realistic sensory feedback associated with practice inoculations applied to the simulated body part,
wherein the blood container comprises a bag and a sponge disposed within the bag, the sponge containing the simulated blood.
30. The simulated body part of claim 29, wherein the substantially realistic sensory feedback includes at least one of substantially realistic haptic feedback and substantially realistic visual feedback.
31. The simulated body part of claim 30, wherein the substantially realistic visual feedback includes simulated bleeding.
32. The simulated body part of claim 30, wherein the substantially realistic visual feedback includes elastic deformation of the simulated body part.
33. The simulated body part of claim 29, wherein the simulated skin covering has a thickness of about ten to one hundred mils and a durometer of about twenty to eighty Shore A.
34. The simulated body part of claim 29, further including a inner core and the blood container is disposed between the simulated skin covering and the inner core, wherein the inner core has a durometer of about fifteen to ninety Shore A.
35. The simulated body part of claim 29, wherein the bag has a wall thickness of about one to twenty mils and a durometer of about forty to one hundred twenty Shore A, and the simulated blood has a viscosity of about fifty to five hundred cps, wherein the simulated body part is adapted to release a predetermined amount of the simulated blood in response to the practice inoculations applied to the simulated body part.
36. The simulated body part of claim 29 further including a inner core and the blood container is disposed between the simulated skin covering and the inner core, wherein the simulated skin covering has a thickness of about ten to one hundred mils and a durometer of about twenty to eighty Shore A, the inner core has a durometer of about fifteen to ninety Shore A, and the bag has a wall thickness of about one to twenty mils and a durometer of about forty to one hundred twenty Shore A, and the simulated blood has a viscosity of about fifty to five hundred cps, wherein the simulated body part is adapted to release a predetermined amount of the simulated blood upon a practice inoculation applied to the simulated body part.
37. A simulated body part, comprising:
a simulated skin covering; and
a blood container containing simulated blood disposed within the simulated skin covering, wherein the simulated body part provides a substantially realistic sensory feedback associated with practice inoculations applied to the simulated body part, wherein the blood container comprises:
a blood reservoir containing simulated blood;
a blood orifice coupled to the simulated skin covering;
a blood pump coupled to the blood reservoir and to the blood orifice, including at least one Nitinol portion coupled to the processor and adapted to squeeze the blood reservoir to generate a hydraulic force; and
a processor adapted to detect the practice inoculations applied to the simulated body part and further adapted to activate the blood pump to generate the hydraulic force to move a predetermined amount of the simulated blood from the blood reservoir to the blood orifice in response to a predetermined number of the practice inoculations applied to the simulated body part.
38. The simulated body part of claim 37, wherein the processor includes a counter adapted to count the predetermined number of practice inoculations, and wherein the processor is adapted to activate the blood pump in response to the counted predetermined number of the practice inoculations.
39. The simulated body part of claim 38, further including a mechanical switch coupled to the simulated skin and to the processor and adapted to sense the practice inoculations.
40. The simulated body part of claim 38, further including at least one of a piezoelectric film and a piezoelectric element coupled to the simulated skin and to the processor and adapted to sense the practice inoculations.
41. The simulated body part of claim 37, wherein the predetermined number of practice inoculations is selectable.
42. The simulated body part of claim 29, wherein the substantially realistic sensory feedback is associated with practice inoculations applied with a bifurcated needle.
43. The simulated body part of claim 29, wherein the substantially realistic sensory feedback is associated with practice inoculations applied with a hypodermic needle.
44. A simulated body part, comprising:
a simulated skin covering; and
an inner core; and
a blood container containing simulated blood, the blood container being disposed between the simulated skin covering and the inner core,
wherein the simulated body part provides a substantially realistic sensory feedback associated with practice inoculations applied to the simulated body part.
45. The simulated body part of claim 44, wherein the substantially realistic sensory feedback is associated with practice inoculations applied with a bifurcated needle.
46. The simulated body part of claim 44, wherein the blood container comprises a bag and a sponge disposed within the bag, wherein the sponge contains the simulated blood.
47. The simulated body part of claim 46, wherein a wall of the bag has a thickness of about one to twenty mils and a durometer of about forty to one hundred twenty Shore A.
US10/552,883 2003-04-14 2004-04-13 Inoculation training kit Expired - Fee Related US7534107B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/552,883 US7534107B2 (en) 2003-04-14 2004-04-13 Inoculation training kit

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US46267403P 2003-04-14 2003-04-14
US46750203P 2003-05-02 2003-05-02
US10/552,883 US7534107B2 (en) 2003-04-14 2004-04-13 Inoculation training kit
PCT/US2004/011346 WO2004093029A2 (en) 2003-04-14 2004-04-13 Inoculation training kit

Publications (2)

Publication Number Publication Date
US20060204939A1 US20060204939A1 (en) 2006-09-14
US7534107B2 true US7534107B2 (en) 2009-05-19

Family

ID=33303098

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/552,883 Expired - Fee Related US7534107B2 (en) 2003-04-14 2004-04-13 Inoculation training kit

Country Status (2)

Country Link
US (1) US7534107B2 (en)
WO (1) WO2004093029A2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090035737A1 (en) * 2007-07-31 2009-02-05 Pocket Nurse Enterprises, Inc. Injection Training Pad
US20100203489A1 (en) * 2009-02-11 2010-08-12 Koster Erika S Method and system for maintaining injection reminders via stuffed doll
US7866984B1 (en) * 2005-04-29 2011-01-11 Jawalekar Shreeniwas R Epidural and combined spinal epidural anesthesia administration instructional aid
US20110024323A1 (en) * 2009-07-28 2011-02-03 Martorano Joseph G Multi purpose personal protection equipment kit
US20110200977A1 (en) * 2008-10-20 2011-08-18 Stiftelsen Arcada Cannulation simulator
US20120301857A1 (en) * 2010-02-11 2012-11-29 Finox Ag Injection training dummy
WO2013126707A1 (en) * 2012-02-24 2013-08-29 Luna Innovations Incorporated Medical training kits and methods to simulate treatment of uncontrolled hemorrhage
US20170316719A1 (en) * 2016-05-02 2017-11-02 Greenville Health System Fistula cannulation simulator
USD882795S1 (en) * 2018-05-07 2020-04-28 Mark L. Anderson Inoculator marker

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0414054D0 (en) 2004-06-23 2004-07-28 Owen Mumford Ltd Improvements relating to automatic injection devices
JP4960252B2 (en) 2004-11-22 2012-06-27 インテリジェクト,インコーポレイテッド Device, system and method for drug delivery
US10737028B2 (en) 2004-11-22 2020-08-11 Kaleo, Inc. Devices, systems and methods for medicament delivery
US7947017B2 (en) 2004-11-22 2011-05-24 Intelliject, Inc. Devices, systems and methods for medicament delivery
US11590286B2 (en) 2004-11-22 2023-02-28 Kaleo, Inc. Devices, systems and methods for medicament delivery
US7648483B2 (en) 2004-11-22 2010-01-19 Intelliject, Inc. Devices, systems and methods for medicament delivery
US8361026B2 (en) 2005-02-01 2013-01-29 Intelliject, Inc. Apparatus and methods for self-administration of vaccines and other medicaments
ES2396745T3 (en) 2005-02-01 2013-02-25 Intelliject, Inc. Devices for medication administration
US8206360B2 (en) 2005-02-01 2012-06-26 Intelliject, Inc. Devices, systems and methods for medicament delivery
US9022980B2 (en) 2005-02-01 2015-05-05 Kaleo, Inc. Medical injector simulation device
US8231573B2 (en) 2005-02-01 2012-07-31 Intelliject, Inc. Medicament delivery device having an electronic circuit system
US20060282030A1 (en) * 2005-06-10 2006-12-14 Martin James C System for forming a structure having load-bearing capabilities
US7621749B2 (en) * 2006-05-05 2009-11-24 Wallcur, Inc. Kit, injectable object, aids and a method of using them for practicing hypodermic needle insertion techniques
CA2651992A1 (en) 2006-06-30 2008-01-10 Abbott Biotechnology Ltd. Automatic injection device
WO2008091838A2 (en) 2007-01-22 2008-07-31 Intelliject, Inc. Medical injector with compliance tracking and monitoring
USD994111S1 (en) 2008-05-12 2023-08-01 Kaleo, Inc. Medicament delivery device cover
US8021344B2 (en) 2008-07-28 2011-09-20 Intelliject, Inc. Medicament delivery device configured to produce an audible output
US10617478B1 (en) 2011-01-03 2020-04-14 Smith & Nephew Orthopedics AG Surgical implement selection process
EP3187216B1 (en) 2011-01-24 2019-08-21 AbbVie Biotechnology Ltd. Automatic injection devices having overmolded gripping surfaces
US9318032B2 (en) * 2011-02-04 2016-04-19 University of Pittsburgh—of the Commonwealth System of Higher Education Hybrid physical-virtual reality simulation for clinical training capable of providing feedback to a physical anatomic model
CA2865236A1 (en) 2012-03-02 2013-09-06 Abbvie Inc. Automatic injection training device
WO2014106096A1 (en) 2012-12-27 2014-07-03 Kaleo, Inc. Devices, systems and methods for locating and interacting with medicament delivery systems
EP3020033B1 (en) * 2013-11-19 2018-01-10 Forschungs und Transferzentrum Leipzig E.V. an der Hochschule für Technik, Wirtschaft und Kultur Leipzig Modular surgical training system
JP7014797B2 (en) 2016-12-23 2022-02-01 カレオ,インコーポレイテッド Drug delivery devices and methods for delivering drugs to babies and children
WO2018136413A2 (en) 2017-01-17 2018-07-26 Kaleo, Inc. Medicament delivery devices with wireless connectivity and event detection
WO2020018433A1 (en) 2018-07-16 2020-01-23 Kaleo, Inc. Medicament delivery devices with wireless connectivity and compliance detection

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2689415A (en) * 1952-07-29 1954-09-21 Harry T Haver Anatomical instruction model
US4182054A (en) * 1978-02-16 1980-01-08 Medical Plastics Laboratory, Inc. Artificial arm
US4773865A (en) * 1987-06-26 1988-09-27 Baldwin Jere F Training mannequin
EP0499125A2 (en) 1991-02-13 1992-08-19 Ambu International A/S Training apparatus for the practice of puncturing blood vessels
US5425644A (en) * 1993-05-13 1995-06-20 Gerhard Szinicz Surgical training apparatus and method
GB2328775A (en) 1997-08-29 1999-03-03 Sami Ahmed Moussa Simulator For Body Organs
US5890908A (en) * 1992-05-13 1999-04-06 University Of Florida Research Foundation Apparatus for and method of simulating the injection and volatilizing of a volatile drug
US5945056A (en) * 1997-05-28 1999-08-31 Simutech Limited Method of making a surgical simulator
EP0951003A1 (en) 1996-11-29 1999-10-20 Eli Lilly Japan K.K. Injection training tool
US20010019818A1 (en) 1999-03-02 2001-09-06 Peter Yong Method of endoscopic cardiac surgery training
US6336812B1 (en) * 1997-06-19 2002-01-08 Limbs & Things Limited Clinical and/or surgical training apparatus
US6488507B1 (en) * 1999-11-29 2002-12-03 Ethicon, Inc. Portable surgical trainer
US20030186203A1 (en) * 2002-03-28 2003-10-02 Aboud Emad T. Method and apparatus for surgical training
US6773263B2 (en) * 2001-10-09 2004-08-10 Robert J. Nicholls Medical simulator
US6863536B1 (en) * 1998-01-26 2005-03-08 Simbionix Ltd. Endoscopic tutorial system with a bleeding complication
US7255565B2 (en) * 2004-03-15 2007-08-14 Brian Keegan Anthropomorphic phantoms and method

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2689415A (en) * 1952-07-29 1954-09-21 Harry T Haver Anatomical instruction model
US4182054A (en) * 1978-02-16 1980-01-08 Medical Plastics Laboratory, Inc. Artificial arm
US4773865A (en) * 1987-06-26 1988-09-27 Baldwin Jere F Training mannequin
EP0499125A2 (en) 1991-02-13 1992-08-19 Ambu International A/S Training apparatus for the practice of puncturing blood vessels
US5215469A (en) * 1991-02-13 1993-06-01 Ambu International A/S Training apparatus for the practice of puncturing blood vessels
US5890908A (en) * 1992-05-13 1999-04-06 University Of Florida Research Foundation Apparatus for and method of simulating the injection and volatilizing of a volatile drug
US5425644A (en) * 1993-05-13 1995-06-20 Gerhard Szinicz Surgical training apparatus and method
EP0951003A1 (en) 1996-11-29 1999-10-20 Eli Lilly Japan K.K. Injection training tool
US5945056A (en) * 1997-05-28 1999-08-31 Simutech Limited Method of making a surgical simulator
US6336812B1 (en) * 1997-06-19 2002-01-08 Limbs & Things Limited Clinical and/or surgical training apparatus
GB2328775A (en) 1997-08-29 1999-03-03 Sami Ahmed Moussa Simulator For Body Organs
US6863536B1 (en) * 1998-01-26 2005-03-08 Simbionix Ltd. Endoscopic tutorial system with a bleeding complication
US20010019818A1 (en) 1999-03-02 2001-09-06 Peter Yong Method of endoscopic cardiac surgery training
US6488507B1 (en) * 1999-11-29 2002-12-03 Ethicon, Inc. Portable surgical trainer
US6773263B2 (en) * 2001-10-09 2004-08-10 Robert J. Nicholls Medical simulator
US20030186203A1 (en) * 2002-03-28 2003-10-02 Aboud Emad T. Method and apparatus for surgical training
US7255565B2 (en) * 2004-03-15 2007-08-14 Brian Keegan Anthropomorphic phantoms and method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PCT Search Report of the ISA for PCT/US2004/011346 received Jun. 4, 2005.
Written Opinion of the ISA for PCT/US2004/011346 received Jun. 4, 2005.

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7866984B1 (en) * 2005-04-29 2011-01-11 Jawalekar Shreeniwas R Epidural and combined spinal epidural anesthesia administration instructional aid
US20090035737A1 (en) * 2007-07-31 2009-02-05 Pocket Nurse Enterprises, Inc. Injection Training Pad
US7988451B2 (en) * 2007-07-31 2011-08-02 Pocket Nurse Enterprises, Inc. Injection training pad
US8690580B2 (en) * 2008-10-20 2014-04-08 Stiftelsen Arcada Cannulation simulator
US20110200977A1 (en) * 2008-10-20 2011-08-18 Stiftelsen Arcada Cannulation simulator
US20100203489A1 (en) * 2009-02-11 2010-08-12 Koster Erika S Method and system for maintaining injection reminders via stuffed doll
US8113845B2 (en) * 2009-02-11 2012-02-14 Koster Erika S Method and system for maintaining injection reminders via stuffed doll
US20110024323A1 (en) * 2009-07-28 2011-02-03 Martorano Joseph G Multi purpose personal protection equipment kit
US8684744B2 (en) * 2010-02-11 2014-04-01 Finox Ag Injection training dummy
US20120301857A1 (en) * 2010-02-11 2012-11-29 Finox Ag Injection training dummy
WO2013126707A1 (en) * 2012-02-24 2013-08-29 Luna Innovations Incorporated Medical training kits and methods to simulate treatment of uncontrolled hemorrhage
US9542861B2 (en) 2012-02-24 2017-01-10 Luna Innovations Incorporated Medical training kits and methods to simulate treatment of uncontrolled hemorrhage
US20170316719A1 (en) * 2016-05-02 2017-11-02 Greenville Health System Fistula cannulation simulator
US11900828B2 (en) 2016-05-02 2024-02-13 University Of South Carolina Fistula cannulation simulator
USD882795S1 (en) * 2018-05-07 2020-04-28 Mark L. Anderson Inoculator marker

Also Published As

Publication number Publication date
WO2004093029A3 (en) 2005-06-30
WO2004093029A2 (en) 2004-10-28
US20060204939A1 (en) 2006-09-14

Similar Documents

Publication Publication Date Title
US7534107B2 (en) Inoculation training kit
Dean et al. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccines against Japanese encephalitis (ChimeriVaxTM-JE) in non-human primates
World Health Organization WHO guidelines on drawing blood: best practices in phlebotomy
Al-Shamiri et al. Knowledge, attitude and practice of hepatitis B virus infection among dental students and interns in Saudi Arabia
KR20080111001A (en) Silicon-based disposable sterile kit for stereotaxy
Al-Hazmi Knowledge, attitudes and practice of dentists concerning the occupational risks of hepatitis B virus in Al Jouf Province, Saudi Arabia
JPH04501212A (en) medical test equipment
Gupta et al. Needlestick injuries in dentistry
Nakamura et al. Monomer permeability of disposable dental gloves
Al Qahtani et al. Knowledge, attitudes and practice of nurses in renal dialysis units regarding infection control in Abha City–Saudi Arabia, 2015
Lokesh et al. Post exposure prophylaxis to occupational injuries for general dentist
Brewer et al. The toxicity and safety testing of disposable medical and pharmaceutical materials
Bennadi et al. Preventive and curative measures adopted by dentists to combat occupational hazards-a cross sectional study
Chaudhry et al. Level of awareness about HIV/AIDS among truck drivers and their attitude towards persons with AIDS
Lawrence et al. Reevaluation of plastic tubings currently used in medical and paramedical applications
Bugti et al. Pyogenic liver abscess: demographic, clinical, radiological and bacteriological characteristics and management strategies
Hadley Infection of the health-care worker by HIV and other blood-borne viruses: Risks, protection, and education
Ali et al. Knowledge Regarding Hepatitis B Virus Infection and its Prevention among Nursing Students in Karachi: Knowledge Regarding Hepatitis B Virus Infection
Gholizadgougjehyaran et al. THE EFFECT OF STAFF PERFORMANCE SKILLS TRAINING BASED ON THE SELF-AWARENESS AND EMPOWERMENT MODELS ON THE RATE OF EXPOSURE TO SHARP OBJECTS AND PATIENTS’SECRETIONS AMONG EMERGENCY NURSES
Al-Gahanin et al. Knowledge, attitude and practice of male secondary school students on hepatitis B in Abha City, Kingdom of Saudi Arabia
Hussain et al. Knowledge and attitude level of nurses about Hepatitis C patient
Solem et al. Richard F. Edlich, MD, PhD Recipient of Distinguished Alumni Award from the University of Minnesota Medical Alumni Society
DeCederfelt et al. Handling of gene-transfer products by the National Institutes of Health Clinical Center pharmacy department
World Health Organization Job aid for COVID-19 vaccine administration: Beijing Institute of Biological Products Co., Ltd.(BIBP) COVID-19 Vaccine, by China National Biotec Group (CNBG), Sinopharm (International non-proprietary name: Covilo; BIBP-CorV)
Baloch et al. Estimation of Risk of Needle Stick Injury and the Level of Awareness of Prophylaxis among the students, House Officers and Supporting Staff of Dentistry.

Legal Events

Date Code Title Description
AS Assignment

Owner name: THE GENERAL HOSPITAL CORPORATION, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BARDSLEY, RYAN S;DAWSON, STEVEN L;WADDINGTON, ROBERT;REEL/FRAME:017219/0911;SIGNING DATES FROM 20040409 TO 20040412

AS Assignment

Owner name: THE GENERAL HOSPITAL CORPORATION, MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BARDSLEY, RYAN S;DAWSON, STEVEN L;WADDINGTON, ROBERT;REEL/FRAME:017247/0164;SIGNING DATES FROM 20051027 TO 20051118

STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: US GOVERNMENT - SECRETARY FOR THE ARMY, MARYLAND

Free format text: CONFIRMATORY LICENSE;ASSIGNOR:THE GENERAL HOSPITAL CORPORATION;REEL/FRAME:023090/0331

Effective date: 20090731

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

SULP Surcharge for late payment

Year of fee payment: 7

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20210519